Wednesday, November 30, 2005


Hep C Virus - Early treatment of hepatitis C effective in HIV-positive patients


Early treatment of hepatitis C effective in HIV-positive patients
Aidsmap - Liver diseases including hepatitis C are an important cause of disease in HIV-positive patients. Although the treatment of chronic hepatitis C infection in HIV-positive patients has been assessed in a number of large

Valeant buys hepatitis treatment from Intermune
Biz Journals - Valeant Pharmaceuticals International said Monday it will acquire the rights to hepatitis C drug Infergen from InterMune Inc. for $113.5 million in cash. is used to treat adult patients suffering from chronic hepatitis C viral infections with compensated liver disease

PR Newswire: Data on Schering-Plough's Oral HCV Protease Inhibitor to be Presented for First Time at American
Belga Direct Press Releases - will bepresented at AASLD, including eight oral presentations.Chronic hepatitis C is estimated to affect more than 10

Fatigue Adversely Affects Virologic Response to Peginterferon Plus Ribavirin
HIV and Hepatitis.com - pegIFN)- -2a combined with RBV for the treatment of chronic hepatitis C [1]), the aim of the study was to Many individuals with chronic hepatitis C also have psychiatric disorders